| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120782 | Journal of Clinical Virology | 2013 | 5 Pages |
Abstract
pp65495-503-specific CD8+ T cells may not be sufficient to control HCMV reactivation in recipients after HSCT. However, the combination of pentamer and IFN-γ-ELISPOT assays may be valuable for evaluating HCMV-specific CD8+ T cells. Further studies on HCMV-specific T-cell immune responses continue to be performed for the prevention of persistent HCMV reactivation.
Keywords
IFN-γHCMVHSCTbusulfanMTXELISPOTPBMCscytosine arabinosideMMFATGCMLMDSPREDGvHDAMLCD8+ T cellsCTLsAra-Chuman leucocyte antigenAntigenaemiaantithymocyte globulinHLACSAEnzyme-linked immunospotGraft-versus-host diseaseFluperipheral blood mononuclear cellsmyelodysplastic syndromeHuman cytomegaloviruscyclosporin ACyclophosphamideFludarabineCytotoxic T lymphocytesAcute lymphoblastic leukaemiaAcute myeloid leukaemiachronic myeloid leukaemiamycophenolate mofetilMethotrexateALLPentamerPrednisoneAllogeneic haematopoietic stem cell transplantationhaematopoietic stem cell transplantationaplastic anaemia
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Anbing Liu, Yadan Ma, Wei Wu, Xiaoming Chen, Yaping Huang, Jianhua Hu, Hanying Liang, Huiqi Wang, Rong Yang, Jun Fan,